Drawing for ACE IMMUNOID

USPTO serial 88057829

ACE IMMUNOID

Reviewed by CopyMark Law Group

Reg. 5702182Status 702Registered
Filing date
Status date
Registration date
Mar 19, 2019
Examiner
NEHMER, JASON ROBERT
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ACE IMMUNOID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura C. Miller

Laura C. Miller Kilpatrick Townsend & Stockton LLP1100 Peachtree Street, Suite 2800Mailstop: IP Docketing - 22Atlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
042Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and developmentACTIVEOct 8, 2015
044Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatmentACTIVEOct 8, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 22, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 22, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Mar 19, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 15, 2018DOCKASSIGNED TO EXAMINER—
Aug 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance